| Identification | Back Directory | [Name]
CGP 57813 | [CAS]
150608-41-6 | [Synonyms]
CGP 57813
Morpholine, 4-[N-[(2R,4S,5S)-5-[[(1,1-dimethylethoxy)carbonyl]amino]-4-hydroxy-2-[(4-methoxyphenyl)methyl]-1-oxo-6-phenylhexyl]-L-valyl-L-phenylalanyl]- | [Molecular Formula]
C43H58N4O8 | [MDL Number]
MFCD00941110 | [MOL File]
150608-41-6.mol | [Molecular Weight]
758.94 |
| Hazard Information | Back Directory | [Description]
CGP 57813 is a lipophilic compound that acts as a inhibitor of human immunodeficiency virus type 1 (HIV-1) protease. | [Uses]
CGP 57813 is a peptidomimetic inhibitor of HIV protease that can be encapsulated by nanoparticles composed of poly(D,L-lactic acid) (PLA) and pH-sensitive methacrylic acid copolymers and delivered into the body[1]. | [References]
[1] Leroux JC, et al. Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice. J Pharm Sci. 1995 Dec;84(12):1387-91. DOI:10.1002/jps.2600841202 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
CHEMICAL LAND21
|
| Tel: |
82- 2 -783 - 8063 |
| Website: |
www.chemicalland21.com |
|